S.M.A.I.O S.A. (EPA:ALSMA)

Market Cap	25.83M -28.4%
Revenue (ttm)	9.30M +12.3%
Net Income	-2.75M
EPS	-0.47
Shares Out	6.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,649
Open	4.570
Previous Close	4.480
Day's Range	4.100 - 4.570
52-Week Range	4.100 - 9.100
Beta	0.61
Analysts	Strong Buy
Price Target	7.60 (+80.95%)
Est. Earnings	Apr 15, 2027

About S.M.A.I.O

S.M.A.I.O S.A. provides software, implantable devices, and associated services for the surgical treatment of spinal deformities. It offers solutions for surgeons, including programs for training, assistance with surgical planning based on KEOPS database. The company also offers solutions, such as i-PLAN platform, a surgical planning solution; i-PERFORM, an assisted execution of the surgical procedure based point by point on the sheet; i-CHECK to measure and monitor the final result based on a data management platform; and i-LEARN, a platform to...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2009
• Employees: 45
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSMA

Financial Performance

In 2025, S.M.A.I.O's revenue was 9.16 million, an increase of 66.67% compared to the previous year's 5.50 million. Losses were -2.23 million, -5.11% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ALSMA stock is "Strong Buy." The 12-month stock price target is €7.60, which is an increase of 80.95% from the latest price.

Price Target

€7.60

(80.95% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 11, 2026

Data Sources Report a data error